Paul Mahon
General Counsel at UNITED THERAPEUTICS CORPORATION
Net worth: 8 M $ as of 2024-03-30
Profile
Paul A.
Mahon is currently the Co-Managing Director at Unither Therapeutik GmbH.
He is also currently serving as the Secretary, Executive VP & General Counsel at United Therapeutics Corp.
and Miromatrix Medical, Inc. In the past, he worked as a Director at SteadyMed Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-03 | 36,710 ( 0.08% ) | 8 M $ | 2024-03-30 |
Paul Mahon active positions
| Companies | Position | Start |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | General Counsel | 2000-12-31 |
| MIROMATRIX MEDICAL INC. | General Counsel | 2023-12-10 |
Unither Therapeutik GmbH
 Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Chief Executive Officer | - |
Former positions of Paul Mahon
| Companies | Position | End |
|---|---|---|
| STEADYMED LTD | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| MIROMATRIX MEDICAL INC. | Health Technology |
| Private companies | 2 |
|---|---|
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Paul Mahon
